BioSpace News Archive

Press Releases

Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for FLT201, its Clinical-Stage Gene Therapy Candidate in Gaucher Disease

May 28, 2025

·

3 min read

Press Releases

Palvella Therapeutics Strengthens Executive Leadership Team with Appointment of Rare Disease Commercial Veteran Ashley Kline as Chief Commercial Officer

May 28, 2025

·

7 min read

Press Releases

Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer

May 28, 2025

·

8 min read

Perspective way to invest money. Hands with dollar sign coins around yellow light bulb over blue background

Clinical research

Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

May 28, 2025

·

12 min read

·

Tristan Manalac

Press Releases

New Subcutaneous Formulation of OPDIVO® Approved in Canada for Use Across All Authorized Solid Tumour Indications

May 28, 2025

·

5 min read

Press Releases

Drug Farm and Xiamen Amoytop Biotech Co., Ltd. Enter into Option Agreement for First-In-Class Innate Immunity Agonist, DF-006 to Treat Hepatitis B and Hepatocellular Cancer

May 28, 2025

·

3 min read

Podcast

COVID-19 Vaccine Overhaul, Rocket Grounded, ‘One Tough Hombre’ on MFN

HHS Secretary RFK Jr. removes the COVID-19 vaccine recommendation for healthy kids and pregnant women—the latest in a string of changes to vaccine policies; judge issues an order to halt HHS’ reorganization and mass layoff plans; Rocket Pharmaceuticals’ pivotal Danon disease trial is on hold after a patient death; and President Trump has named Mehmet Oz to spearhead his Most Favored Nation drug pricing policy.

May 28, 2025

·

2 min read

·

Heather McKenzie